Home › Funds › Cormorant Asset Management, LP › CRBP
Cormorant Asset Management, LP position in CRBP
CORBUS PHARMACEUTICALS · Health Care
Cormorant Asset Management, LP reported holding 2,344,971 shares of CRBP (CORBUS PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$22.0M, representing 1.13% of its reported portfolio and ranking #25 among its reported holdings. Cormorant Asset Management, LP has disclosed CRBP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's CRBP position evolved
Cormorant Asset Management, LP first disclosed a stake in CRBP in Q1 2024 at 2,025,000 shares (US$79.5M). The position peaked in Q2 2024 at 2,025,000 shares, worth US$91.6M. Across 10 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 2,344,971 shares valued at US$22.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.02M | $79.46M | New |
| Q2 2024 | 2.02M | $91.63M | Hold |
| Q3 2024 | 2.38M | $49.00M | Add |
| Q4 2024 | 2.38M | $28.02M | Hold |
| Q1 2025 | 2.38M | $12.61M | Hold |
| Q2 2025 | 2.38M | $16.39M | Hold |
| Q3 2025 | 2.38M | $30.04M | Hold |
| Q4 2025 | 2.34M | $19.09M | Reduce |
| Q1 2026 | 2.34M | $22.02M | Hold |
| Q2 2026 | 2.34M | $22.00M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRBP and 13F data
CRBP (CORBUS PHARMACEUTICALS) is a Health Care company. 24 other funds we track also report a position in CRBP — the largest reported positions include Jones Hill Capital LP (US$6.1M), Prosight Management, LP (US$6.1M), Stonepine Capital Management, LLC (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRBP
- Jones Hill Capital LP 653.57K sh · $6.13M · Q2 2026
- Prosight Management, LP 650.00K sh · $6.10M · Q2 2026
- Stonepine Capital Management, LLC 425.00K sh · $3.99M · Q2 2026
- DIADEMA PARTNERS LP 301.26K sh · $2.83M · Q2 2026
- Exome Asset Management LLC 184.91K sh · $1.73M · Q2 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held CRBP?
Cormorant Asset Management, LP has disclosed CRBP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is Cormorant Asset Management, LP's current position in CRBP?
As of Q2 2026, Cormorant Asset Management, LP holds 2.34M shares of CRBP (CORBUS PHARMACEUTICALS), valued at $22.00M, representing 1.13% of its reported portfolio and ranking #25.
Has Cormorant Asset Management, LP been buying or selling CRBP?
In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP held unchanged its position in CRBP. The position peaked in Q2 2024 at 2.02M shares.
Which other funds hold CRBP?
Other major institutional holders of CRBP include Jones Hill Capital LP, Prosight Management, LP, Stonepine Capital Management, LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.